Related Experiment Video
Updated: Sep 6, 2025

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
Published on: March 24, 2013
Visualizing Lysosomal Positioning with a Fluorescent Probe Reveals a New Synergistic Anticancer Effect
Kaixin Yu1, Yufeng Ding2, Hua Yu2
1Key Laboratory of Green Chemistry and Technology (Ministry of Education), College of Chemistry, Sichuan University, Chengdu 610064, China.
Researchers developed NIM-3, a fluorescent probe for visualizing lysosome dynamics. This led to discovering a novel cancer therapy combining tumor necrosis factor alpha (TNFα) and chloroquine (CQ).
Area of Science:
- Cell Biology
- Cancer Therapeutics
- Fluorescent Probes
Background:
- Lysosome dynamics are crucial for cellular functions and cancer development.
- Understanding lysosome behavior can lead to novel cancer treatment strategies.
Purpose of the Study:
- To develop a fluorescent probe for visualizing lysosome dynamics.
- To investigate lysosome behavior in response to stimuli.
- To identify new anticancer therapeutic approaches targeting lysosomes.
Main Methods:
- Development of NIM-3, a lysosome-targetable fluorescent probe with high selectivity, photostability, and low cytotoxicity.
- Utilizing NIM-3 for spatial and temporal imaging of lysosomal dynamics.
- Analyzing lysosomal positioning and behavior in various cell types.
Main Results:
- NIM-3 enabled the definition of three distinct types of lysosome motion.
- Observed perinuclear accumulation of lysosomes upon stimulation with pro-inflammatory cytokines.
- Disclosed a potential anticancer therapy combining chloroquine (CQ) and tumor necrosis factor alpha (TNFα).
- Verified the efficacy of the "CQ + TNFα" treatment across diverse human cancer cells.
- Anticancer mechanism potentially linked to lysosomal dilation.
Conclusions:
- The developed fluorescent probe NIM-3 is effective for studying lysosome dynamics.
- Lysosome behavior, including perinuclear accumulation, can be modulated by external stimuli.
- The combination of CQ and TNFα represents a promising new strategy for cancer therapy, potentially through lysosomal dilation.
More Related Videos
10:25Dual-color Correlative Light and Electron Microscopy for the Visualization of Interactions between Mitochondria and Lysosomes
Published on: September 27, 2024
10:26Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
Published on: November 1, 2017